Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy
- PMID: 31431803
- PMCID: PMC6685107
- DOI: 10.1177/1179558119867357
Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy
Abstract
Extraction of ovarian tissue prior to oncologic therapy and subsequent transplantation is being performed increasingly often to preserve fertility in women. The procedure can be performed at any time of the cycle and, therefore, generally does not lead to any delay in oncological therapy. Success rates with transplantation of cryopreserved ovarian tissue have reached promising levels. More than 130 live births have been reported worldwide with the aid of cryopreserved ovarian tissue and the estimated birth rate is currently approximately 30%. In Germany, Austria, and Switzerland, the FertiPROTEKT consortium has successfully achieved 21 pregnancies and 17 deliveries generated after 95 ovarian tissue transplantations by 2015, one of the largest case series worldwide confirming that ovarian tissue cryopreservation and transplantation are successful. Approximately, more than 400 ovarian tissue cryopreservation procedures are performed each year in the FertiPROTEKT consortium, and the request and operations for ovarian tissue transplantation have increased in recent years. Therefore, recommendations for managing transplantation of ovarian tissue to German-speaking reproductive medicine centers were developed. In this overview, these recommendations and our experience in ovarian tissue transplantation are presented and discussed with international procedures.
Keywords: FertiPROTEKT; Fertility preservation; gonadotoxic treatment; ovarian tissue cryopreservation; ovarian tissue transplantation; pregnancy after chemotherapy.
Conflict of interest statement
Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Dittrich R, Kliesch S, Schüring A, et al. Fertility preservation for patients with malignant disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017)—recommendations and statements for girls and women. Geburtshilfe Frauenheilkd. 2018;78:567-584. - PMC - PubMed
-
- Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Reprod (Oxford, England). 2017;32:1046-1054. - PubMed
-
- Lotz L, Maktabi A, Hoffmann I, Findeklee S, Beckmann MW, Dittrich R. Ovarian tissue cryopreservation and retransplantation—what do patients think about it. Reprod Biomed Online. 2016;32:394-400. - PubMed
-
- Donnez J, Garcia-Solares J, Dolmans MM. Ovarian endometriosis and fertility preservation: a challenge in 2018. Minerva Ginecol. 2018;70:408-414. - PubMed
LinkOut - more resources
Full Text Sources
